Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

January 21, 2021
Open Access

The antimicrobial potential of cannabidiol.

Communications Biology
Mark A T BlaskovichMichael Thurn
January 21, 2021
Case Report

[A Case of Cytomegalovirus Reactivation after Chemoradiotherapy for Esophageal Cancer].

Gan to kagaku ryoho. Cancer & chemotherapy
Shinichi AdachiRiichiro Nezu
January 20, 2021
Open Access

Streptococcus pneumoniae coinfection in hospitalised patients with COVID-19.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
Vanesa Anton-Vazquez, Raquel Clivillé
January 19, 2021

The nasopharyngeal microbiota of preweaned dairy calves with and without ultrasonographic lung lesions

Journal of Dairy Science
S M RaabisT L Ollivett
January 21, 2021

Antibiotic therapy versus no antibiotic therapy for children aged 2 to 59 months with WHO-defined non-severe pneumonia and wheeze.

The Cochrane Database of Systematic Reviews
Zohra S LassiZulfiqar A Bhutta
January 22, 2021
Open Access

Negative Excess Mortality in Pneumonia Death caused by COVID-19 in Japan

MedRxiv : the Preprint Server for Health Sciences
Junko KuritaY. Ohkusa
January 23, 2021

Murine Myeloid Progenitors Attenuate Immune Dysfunction Induced by Hemorrhagic Shock.

Stem Cell Reports
Joshua T CohenCraig T Lefort
January 19, 2021

Pulmonary Hypertension in COVID-19 Pneumoniae: It Is Not Always as It Seems

European Journal of Case Reports in Internal Medicine
Maria Cristina PasqualettoFausto Rigo
January 22, 2021
Open Access

Specific Antibody Deficiency in Adult Patients With IgG or IgG Subclass Deficiency.

Allergy, Asthma & Immunology Research
Joo Hee KimHae Sim Park
January 21, 2021

Pneumonia in older adults.

Current Opinion in Infectious Diseases
Christian Davis FurmanForest W Arnold
January 18, 2021
Open Access

Peptidoglycan analysis reveals that synergistic deacetylase activity in vegetative Clostridium difficile impacts the host response

The Journal of Biological Chemistry
Héloise CoullonThomas Candela
January 21, 2021
Open Access

Severe COVID-19 Lung Infection in Older People and Periodontitis.

Journal of Clinical Medicine
Ruben Aquino-Martinez, Scarlette Hernández-Vigueras
January 21, 2021

Characterization and distribution of viridans group streptococci isolated from infectious endophthalmitis and keratitis.

Arquivos brasileiros de oftalmologia
Katiane SantinAna Luisa Hofling-Lima

Sign up to follow this feed and discover related papers.

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Ascariasis (ASM)

Ascariasis is a helminthic infection of global distribution with more than 1.4 billion persons infected throughout the world. Here is the latest research.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

© 2021 Meta ULC. All rights reserved